Quanta receives FDA 510(k) clearance for its SC+ Hemodialysis System

News, Portfolio

8th January 2021

Quanta, the British medical technology pioneer developing innovative dialysis products and services for the global market, today announces it has received 510(k) clearance from the US Food and Drug Administration (“FDA”) to market its small and simple, high performance hemodialysis system SC+.

This critical milestone enables Quanta to bring to the American market its portable device that can provide a dialysis dose equivalent to today’s standard of care, but in a compact, easy-to-use format suitable for a range of care settings.

Read more here.

Press enter or esc to cancel